What are the risks and side effects of starting TRT in your 30s?

Short answer: testosterone replacement therapy (TRT) can help men with clinically low testosterone, but starting it in your 30s carries important risks—most importantly substantial, often-prolonged suppression of fertility—plus other metabolic, hematologic, mood, and prostate-related side effects. You should discuss risks, alternatives, and monitoring with a urologist or endocrinologist before starting, and consider sperm banking if you may want biological children.

Main risks and side effects

• Fertility suppression and testicular atrophy

  • Exogenous testosterone suppresses the hypothalamic‑pituitary‑gonadal axis → lower LH/FSH → big drops in sperm production and testicular size. Sperm counts can fall to oligospermia or azoospermia within months.
  • This is often reversible after stopping TRT but recovery can take many months to >1–2 years and is not guaranteed. The younger you are, the better the chance of recovery, but infertility remains the biggest practical risk for men in their 30s.

• Erythrocytosis (high red blood cell mass)

  • TRT commonly raises hematocrit; if hematocrit goes >54% it increases risk of blood clots, stroke, myocardial infarction.
  • Requires routine CBC monitoring and occasional phlebotomy if high.

• Acne, oily skin, hair changes and gynecomastia

  • Acne and scalp hair loss (if genetically predisposed) are common; aromatization to estradiol can cause breast tissue enlargement in some men.

• Mood and behavioral changes

  • Can improve mood and energy for some, but can also cause irritability, aggression, mood swings, or exacerbate anxiety/depression in others.

• Sleep apnea

  • TRT can worsen or unmask obstructive sleep apnea.

• Lipids and metabolic effects

  • TRT can lower HDL cholesterol and may modestly affect other lipids; long-term cardiovascular effects are uncertain—some studies show increased risk in certain groups, others show benefits. Risk likely varies by individual cardiovascular profile.

• Prostate effects

  • TRT can raise PSA and prostate volume; no clear evidence that TRT causes de novo prostate cancer, but it could stimulate growth of an existing cancer. Baseline PSA and periodic monitoring are standard.

• Liver toxicity (mostly with older/oral preparations)

  • 17-alpha-alkylated oral testosterones (rarely used) have hepatic toxicity. Newer oral undecanoate formulations (Jatenzo) and injectables are less hepatotoxic but need monitoring.

• Local adverse effects

  • Skin irritation with gels/patches; injection-site pain or oil‑related complications with some long‑acting intramuscular formulations (rare pulmonary oil microembolism risk with some products like Aveed).

What to expect on a timeline

• Weeks to months: acne, mood changes, increased libido, suppression of LH/FSH and falling sperm counts (often within 2–3 months), rising hematocrit.
• Months to years: possible improvements in energy/sexual function for some; fertility recovery (if you stop therapy) can take many months to years.

Mitigation and monitoring

• Baseline tests: total and free testosterone, LH, FSH, prolactin, CBC (hematocrit/hemoglobin), PSA, lipids, LFTs, and consider semen analysis if fertility matters.
• Ongoing monitoring: testosterone level and hematocrit ~3 months after start and then every 3–12 months; PSA and digital rectal exam per guidelines; lipid panel and LFTs periodically; mood/sleep assessment.
• If hematocrit rises, dose adjust or do therapeutic phlebotomy.
• If fertility is important, discuss alternatives or adjuncts (below) and consider sperm banking before starting TRT.

Alternatives and fertility‑preserving options

• Clomiphene citrate (Clomid) — a SERM that can raise endogenous testosterone by stimulating the HPT axis; preserves fertility because it increases LH/FSH.
• Human chorionic gonadotropin (hCG) — preserves intratesticular testosterone and spermatogenesis when used alone or with TRT.
• Selective use of aromatase inhibitors (anastrozole) in some cases to control estrogen conversion (used carefully).
• Nasal testosterone (Natesto) or lower-dose/transdermal regimens may have different suppression profiles but do not guarantee preserved fertility.
• If you plan children: consider sperm banking at a reputable fertility clinic before starting TRT.

Recommended specialists, brands and services (why)

• Specialists: see a urologist (especially one who treats male infertility) or an endocrinologist for evaluation and shared decision-making. They’ll tailor therapy to goals (symptom relief vs fertility).
• Telehealth consumer TRT services: Roman, Hims, Vault Health — convenient for follow-ups and prescriptions, but make sure they do appropriate baseline testing and discuss fertility risks; for fertility concerns, prefer an in‑person specialist.
• Common TRT formulations (examples)
  • Injectable: testosterone cypionate (generic/Depo‑Testosterone) — commonly used, flexible dosing.
  • Long‑acting injectable: testosterone undecanoate (Aveed in US; Nebido internationally) — less frequent dosing but special administration/monitoring (Aveed has rare pulmonary oil microembolism risk).
  • Gels: AndroGel, Testim, Fortesta — easy to use but risk of transfer to others/skin irritation.
  • Patch: Androderm — steady delivery but can cause skin irritation.
  • Nasal: Natesto — multiple daily doses, sometimes used when topical transfer is a concern.
  • Oral: Jatenzo (testosterone undecanoate) — FDA‑approved oral option but requires BP and LFT monitoring; older methyltestosterone products have higher liver risk and are generally avoided.
• Labs and monitoring: LabCorp and Quest Diagnostics are widely used for testing. For fertility preservation, use a reputable local fertility clinic/academic center for sperm banking.

What you should do next

1. Get a full evaluation (symptoms + morning testosterone on at least two occasions with corresponding LH/FSH) from a urologist or endocrinologist.
2. If you may want children, consider semen analysis and sperm banking before starting TRT.
3. Discuss alternatives (clomiphene, hCG) if fertility preservation is a priority.
4. If you and your clinician decide on TRT, set up baseline labs and a monitoring schedule (CBC, testosterone, PSA, lipids, LFTs, mood/sleep checks).

If you want, tell me:

• whether you’ve had baseline labs (testosterone, LH/FSH, semen analysis), and
• whether you plan to have children—I can suggest specific next steps and which formulation/approach might best fit your goals.